Healthcare -
Biotechnology - NASDAQ - US
$ 67.08
-9.6 %
$ 4.82 B
Market Cap
-17.35
P/E
NUVL - REVENUE
Revenue NUVL - Nuvalent, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR